Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMOSB.L Regulatory News (MOSB)

  • There is currently no data for MOSB

Rule 8.1-Moss Bros Group plc

27 May 2008 13:04

RNS Number : 3106V
Charles Stanley & Co. Ltd.
27 May 2008
 



FORM 8.1

 

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)

1. KEY INFORMATION

Name of person dealing (Note 1)

Mr Rowland Gee and Mrs Elizabeth Ann Gee

 

Company dealt in

Moss Bros Group plc

 

Class of relevant security to which the dealings being disclosed relate (Note 2)

 

Ordinary

Date of dealing

23 May 2008

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

2,201,385 2.3%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

2,201,385 2.3%

This represents the combined holding of Mr & Mrs Gee. Please see section 4 below for further details.

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

Sale

64,500

ÂŁ0.45GBP

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5) 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

The ordinary shares sold on 23 May 2008 were beneficially owned by Mrs Elizabeth Ann Gee, wife of Mr Rowland Gee.

Of the resulting interest disclosed in 2(a)(i) above, 2,200,264 ordinary shares are beneficially owned by Mr Rowland Gee and 1,121 by Mrs Elizabeth Ann Gee.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

27 May 2008

 

Contact name

Robert Howard

 

Telephone number

0207 953 2154

 

Name of offeree/offeror with which associated

Moss Bros Group plc

 

Specify category and nature of associate status (Note 10)

Associate of offeree

 

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCSEWFFWSASEII
Date   Source Headline
10th Jun 20197:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
15th May 20193:36 pmRNSResults of AGM
15th May 20197:00 amRNSAGM Trading Update
13th May 201910:40 amRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSAnnual Financial Report Notice of Release
26th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSDirectorate Change
11th Jan 20197:00 amRNSTrading Update
24th Dec 20187:00 amRNSDirectorate Change
7th Nov 20182:20 pmRNSDirector Declaration
15th Oct 201812:07 pmRNSSecond Price Monitoring Extn
15th Oct 201812:02 pmRNSPrice Monitoring Extension
28th Sep 20184:35 pmRNSPrice Monitoring Extension
21st Sep 20187:00 amRNSHalf-year Report
8th Aug 201812:28 pmRNSHolding in Company
11th Jul 20184:30 pmRNSNotification of Major Holdings
20th Jun 20189:29 amRNSHolding in Company
18th Jun 201810:16 amRNSHolding in Company
15th Jun 201812:07 pmRNSSecond Price Monitoring Extn
15th Jun 201812:02 pmRNSPrice Monitoring Extension
14th Jun 20189:24 amRNSHolding in Company
12th Jun 201812:07 pmRNSSecond Price Monitoring Extn
12th Jun 201812:02 pmRNSPrice Monitoring Extension
4th Jun 20185:14 pmRNSHolding in Company
22nd May 20182:49 pmRNSDirector/PDMR Shareholding
16th May 20183:26 pmRNSResults of AGM
16th May 20187:00 amRNSDirectorate Change
16th May 20187:00 amRNSTrading Update
11th May 20182:22 pmRNSDirector/PDMR Shareholding
8th May 201811:02 amRNSHolding in Company
1st May 201810:03 amRNSDirector/PDMR Shareholding
1st May 20189:28 amRNSHolding in Company
16th Apr 20183:59 pmRNSAnnual Financial Report
4th Apr 20184:40 pmRNSSecond Price Monitoring Extn
4th Apr 20184:35 pmRNSPrice Monitoring Extension
4th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 20184:40 pmRNSSecond Price Monitoring Extn
29th Mar 20184:35 pmRNSPrice Monitoring Extension
28th Mar 20187:00 amRNSDirector Declaration
27th Mar 20187:00 amRNSPreliminary Results
21st Mar 20187:00 amRNSTrading Update
13th Mar 201812:02 pmRNSPrice Monitoring Extension
12th Mar 20184:40 pmRNSSecond Price Monitoring Extn
12th Mar 20184:35 pmRNSPrice Monitoring Extension
19th Feb 20184:41 pmRNSSecond Price Monitoring Extn
19th Feb 20184:35 pmRNSPrice Monitoring Extension
16th Feb 20184:40 pmRNSSecond Price Monitoring Extn
16th Feb 20184:35 pmRNSPrice Monitoring Extension
14th Feb 20189:00 amRNSHolding in Company
15th Jan 201810:37 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.